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Abstract
Background: The distribution of adipose tissue has been evaluated in relation to cardiovascular risk factors and
biochemical components of the metabolic syndrome. Neck circumference (NC) has been shown to have a strong
relationship with cardiovascular disease (CVD) and may be a novel indicator of CVD. The aim of this study was to
compare the incidence of CVD events in cohorts with different NC distributions, and to correlate NC with future
CVD events and relative mortality.
Methods: A prospective cohort study was performed on 12,151 high-risk cardiology outpatients from 2004 until
2014. Anthropometric parameters like body mass index, NC, waist circumference, and hip circumference were
measured at baseline and follow-up and compared in different cohorts with high, medium, and low NC. Fatal and
non-fatal CVD events were compared in the follow-up study, and survival analysis was conducted. Independent
Chi-square tests were performed to compare the incidence of CVD events and mortality among the cohorts and
analyze the interactions.
Results: The subjects comprised of 6696 women and 5819 men who completed a mean 8.8-year follow-up. All of
the participants had two or more CVD risk factors at baseline. At the end of the study, 4049 CVD events had
occurred in 2304 participants. The incidence of non-fatal CVD events was 14.08, 16,65, and 25.21 % in the low-NC,
medium-NC, and high-NC cohorts, respectively (p < 0.001). The all-cause mortality was 9.77, 11.93, and 19.31 %, and
CVD mortality, 4.00, 6.29, and 8.01 %, respectively (p < 0.001). Compared with baseline, the number of CVD risk
factors in participants had increased from 2.6, 3.0, and 3.4 to 3.5, 4.1, and 4.7 in the low-, medium-, and high-NC
cohorts (34, 36, and 38 %), respectively. The event-free survival rate was 95.32, 80.15, and 75.47 %, respectively.
Conclusions: A higher NC indicated a higher incidence of future fatal and non-fatal CVD events and all-cause
mortality in both male and female high-risk participants. CVD risk factors increased more in the higher NC group.
NC as a novel indicator of CVD showed good predictive ability for CVD events and mortality in a high-risk
population.
Background
Body obesity is associated with an increased risk of de-
veloping metabolic syndrome, type 2 diabetes (T2DM),
and hypertension and is considered a major risk factor
for cardiovascular disease (CVD) events and early mor-
tality. Excessive adiposity is involved in the pathogenesis
of coronary heart disease (CHD), since it is closely asso-
ciated with the development of hypertension, dyslipid-
emia, and T2DM [1].
In addition to obesity, the distribution of body weight is
considered to be an important aspect of metabolic syn-
drome, and is a stronger predictor of cardiovascular risk.
The preferential accumulation of body fat in specific re-
gions is related to disease risk [2]. Generally, visceral and
subcutaneous fat are associated with insulin resistance [3].
Visceral adipose tissue is a unique pathogenic fatty deposit
that is strongly implicated in the pathogenesis of insulin
resistance, T2DM, and ischemic heart disease [4], and
closely correlated with the risk of CVD. Due to its corres-
pondence with visceral adipose tissue, waist circumference
(WC) is widely used to identify central obesity and is
* Correspondence: hmu.xueqili@outlook.com
The Fourth Affiliated Hospital of Harbin Medical University, 37 Yiyuan Street,
Habin 150001, China
© 2016 Dai et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Dai et al. Lipids in Health and Disease  (2016) 15:46 
DOI 10.1186/s12944-016-0218-3
designated as one of the criteria for metabolic syndrome
in several clinical definitions. Previous studies have estab-
lished the relationship between central obesity and the
development of CVD [5, 6].
Recent interest is focused on the possible involvement
of adiposity as a linking factor in cardiovascular risk.
Through direct paracrine effects, locally acting fat depots
may contribute to the complications of obesity, in particu-
lar vascular disease [7]. Therefore, cardiovascular risk is
conferred by specific fat distribution patterns, particularly
upper body adiposity, which is as a strong determinant in
the population and more strongly associated with glucose
intolerance, hyperinsulinemia, diabetes, hypertriglyc-
eridemia, and gout than is lower-body obesity.
Neck circumference (NC), has been evaluated as an
index for the distribution of upper-body subcutaneous
adipose tissue in relation to cardiovascular risk factors [8]
and insulin resistance, and has also been shown to correl-
ate positively with biochemical components of the meta-
bolic syndrome [9]. NC is a valid marker for identifying
obese individuals and correlates well with other anthropo-
metric measurements. NC has been independently corre-
lated with cardio-metabolic risk factors above and beyond
their relationships with other adiposity measures [10, 11].
However, it is unclear whether NC could predict
the incidence of cardiovascular events and mortality.
Based on these findings, we hypothesized that NC
could predict the incidence of cardiovascular events
such as acute coronary syndrome, myocardial infarc-
tion, percutaneous coronary intervention, and sudden
cardiac death. The aim of this study was to compare the
incidence of CVD events in cohorts with different fat distri-




Between February 2004 and December 2006, a total
of 18,975 consecutive adults with two or more CVD
risk factors who had visited the outpatient clinic of
cardiology department in the Fourth Affiliated Hos-
pital of Harbin Medical University were recom-
mended to participate in this study. The definition of
CVD risk factors adopted for this study was based on
that given by the International Diabetes Federation,
which included central obesity based on WC (WC ≥
85 cm for men; WC ≥ 80 cm for women in the Chinese
population), with the addition of at least two of the follow-
ing four factors: increased triglyceride (TG) (≥1.7 mmol/L),
decreased high-density lipoprotein cholesterol (HDL-C)
(≤1.03 mmol/L for men and ≤1.29 mmol/L for women),
high blood pressure (BP) (SB ≥ 130 or DBP ≥ 85 mmHg),
and increased fasting plasma glucose (FPG) (≥5.60 mmol/L)
[12]. The Exclusion criteria were as follows: subjects with
goiter and other neck masses and deformities; pregnancy;
people with severe disabilities or systemic disease, hepatic
failure, renal failure; and subjects with diagnosed CVD or
T2DM. For all deaths, we sought death certificates, or med-
ical record numbers when appropriate, to understand the
cause of death.
After exclusion criteria were applied, 12,151 subjects
in total agreed to participate in the longitudinal
cohort study, aged 24 to 64 years (47.9 ± 17.7 years,
46.5 % men). The protocol and informed consent
documents were approved by the ethics committee of
the Fourth Affiliated Hospital of Harbin Medical Uni-
versity. All patients gave written informed consent.
Every two years, participants were requested to undergo a
clinical examination including blood pressure, blood tests,
anthropometric measures, and a self-report medical
history review for the mean 8.8 ± 2.1 years of follow-up
study.
Study design
Subjects were categorized on the basis of their NC level, ac-
cording to the Beijing Community Diabetes Study [13]. The
NC categories were as follows: low NC, <33 cm for women
and <36 cm for men; medium NC, 33 ≤NC< 37 cm for
women and 36 ≤NC< 40 cm for men; high NC, ≥37 cm
for women and ≥40 cm for men. BMI was categorized on
the basis of the following criteria [14]: normal weight,
BMI < 23.99; overweight, 24.00 ≤ BMI < 28.00; obese,
BMI ≥ 28.00. All subjects underwent a complete medical
examination, a clinical consultation, and blood laboratory
tests. All individuals provided details of their demo-
graphic, medical history, and use of medication at base-
line. Subsequent visits were conducted within 6 months of
the specified time when subjects were having regular out-
patient appointments, were hospitalized because of CVD
events, or had made an appointment at the clinic. An-
thropometric measures and biomarkers were assessed on
each visit.
Cardiovascular events such as acute coronary syndrome,
myocardial infarction, percutaneous coronary intervention
(performed by clinical doctors), and sudden cardiac death,
as well as all-cause death (based on clinical documents)
were recorded. Incident cardiovascular morbidity and fatal
events were validated by reviewing hospital records and the
records of attending physicians, and were classified by an
external endpoint committee of cardiologists and doctors.
Myocardial infarction was defined as either nonfatal
acute myocardial infarction or coronary death. Since it
is difficult to perform coronary angiograms on every
patient, diagnoses were based on hospital records of
symptoms, electrocardiographic signs, enzyme levels
(creatine kinase, as well as troponin T or I), and
necropsy.
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Anthropometric measures
NC (cm) was measured with the head erect and eyes fa-
cing forward, by using a flexible tape positioned horizon-
tally at the upper margin of the laryngeal prominence.
Trained doctors or medical students performed the
measurement twice. The average of the two results was
adopted. Height and body weight were measured with
participants standing without shoes and heavy outer gar-
ments. Body weight was measured in light clothing to
the nearest 0.1 kg, and height to the nearest 0.5 cm.
BMI was calculated as weight (in kilograms) divided by
height (in meters) squared. WC was the minimum ab-
dominal girth measured to the nearest 0.1 cm. BP was
measured by doctors by using a mercury manometer
after the subject had rested for at least 5 min. Three
measurements were taken, 5 min apart. The mean of
the three measurements was used for the analysis.
Hypertension was defined as SBP ≥140 mmHg and
DBP ≥90 mmHg.
Biomarkers assessment
Venous blood samples were drawn from all subjects
after they fasted overnight (10 h). The blood was trans-
ferred into glass tubes and allowed to clot at room
temperature. Immediately after clotting, the serum was
separated by centrifugation at 3000 rpm for 15 min.
Plasma glucose was measured by using the hexokinase
glucose-6-phosphate dehydrogenase method. The levels
of total cholesterol (TC), TG, HDL-C, and low-density
lipoprotein cholesterol (LDL-C) were determined enzy-
matically by using an auto-analyzer (Type C8000; Roche
Ltd, Germany). Hemoglobin A1c (HbA1c) was measured
by using high performance liquid chromatography
(HPLC; HLC-723G7 hemoglobin HPLC analyzer, Tosoh
Corp.) according to the standardized method.
The 1999 World Health Organization diagnostic criteria
were used to diagnose diabetes. National Cholesterol Educa-
tion Programme guidelines were used to define dyslipidemia
as follows [15]: hypercholesterolemia, serum cholesterol
Fig. 1 Flow chart of participants’ recruitment
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levels ≥200 mg/dL (≥5.2 mmol/L); hypertriglyceridemia,
serum TG levels ≥150 mg/dL (≥1.7 mmol/L); low HDL
cholesterol, HDL cholesterol levels <40 mg/dL
(<1.04 mmol/L) for men and <50 mg/dL (<1.3 mmol/L)
for women; high LDL cholesterol, and LDL cholesterol
levels ≥130 mg/dL (≥3.4 mmol/L).
Statistical analysis
All data were analyzed by using SPSS 17.0 software. All
continuous data are presented as mean ± standard devi-
ation (SD) or percentages. Chi-square tests were used to
examine differences between categorical data at baseline
and follow-up. Changes over the 8.8-year follow-up
period were assessed by using repeated measures
ANOVA. Data were tested for equality of variance, and a
correction for unequal variances was performed when
appropriate. All tests of significance were two tailed.
Statistical significance was based on a p value of <0.05.
Results
There were 18, 975 subjects who visited the outpatient
clinic of the cardiology department of the Fourth Affili-
ated Hospital of Harbin Medical University in search of
help for a cardiovascular problem. After an initial
screening, we excluded those whose results did not meet
the inclusion criteria (n = 2370). Of the patients who
were invited to participate in this study, 74.4 % agreed
and provided informed consent. During the average
8.8 years of follow-up, 205 subjects withdrew because of
migration or loss of contact. Subjects in our study were
assigned to one of three cohorts according to their NC
levels. There were 2757, 6059, and 3697 participants in-
cluded in the low, medium, and high NC groups, re-
spectively. At the end of the follow-up study, 10.87, 8.22,
and 13.55 % had died from all causes in these three co-
horts, respectively (Fig. 1).
Demographic characteristics and CVD risk factors are
displayed in Table 1. The study sample consisted of 12,515
individuals, with 6696 (53.50 %) women and 5819 men, a
mean age of 47.9 ± 17.7 years, and BMI of 26.31 ± 4.48. All
the participants had two or more CVD risk factors. Except
for age, HC, WHR, and TG, the other variables were not
significantly different between the sexes. Both the sex
groups had high levels of FGP, TC, TG, LDL, and a high
percentage of smoking and alcohol consumption at base-
line. Of the 12,515 subjects, the metabolic syndrome was
diagnosed in 2113 (18.66 %), high BP in 4928 (39.38 %),
increased FPG in 1872 (14.96 %), increased TG in 4975
(39.75 %), decreased HDL in 3487 (27.86 %), increased
LDL in 6711 (53.62 %), and increased TC in 8361
(66.81 %) participants.
At the end of the follow-up study, 4049 CVD events
had occurred in 2304 participants. The incidence of
non-fatal CVD events was 14.08 % in the low-NC co-
hort, 16.65 % in the medium-NC cohort, and 25.21 % in
the high-NC cohort (p < 0.001). The all-cause mortality
was 9.77, 11.93, and 19.31 %, and CVD mortality was
4.00, 6.29 and 8.01 %, respectively (p < 0.001). After a
mean follow-up of 8.8 years (90,605 person-years), we
observed 1404 nonfatal CVD events in 859 men and 645
women, and 2014 deaths (835 CVD deaths, 41.5 %) in
1175 men (505 CVD deaths, 43.0 %) and 839 women
(430 CVD deaths, 51.0 %).
When categorized by NC into three groups, an in-
creased risk level for CVD with increased NC was ob-
served (Fig. 2). The interaction between NC and BMI on
the incidence of CVD events, all-cause mortality, and
CVD mortality were also analyzed. Within each NC
group, there was a stepwise increase in the incidence of
CVD events, all-cause mortality, and CVD mortality in
men and women (p < 0.001). Among the men, there was a
significant interaction between NC and the incidence of
CVD events (p < 0.005), all-cause mortality (p < 0.001), and
CVD mortality (p < 0.05). Among the women, a significant
interaction was also seen between NC and the incidence of
CVD events (p < 0.05), all-cause mortality (p < 0.001), and
CVD mortality (p < 0.001). After a mean 8.8-year follow-
up, 4049 CVD events had occurred among 2304 partici-
pants at baseline, including 1259 women (incidence
18.8 %), and 1045 men (incidence 17.96 %). Despite the
presence of CVD events, in all the 12,515 participants at
Table 1 Characteristics of participants at baseline
Women Men p value
n = 6696 n = 5819
Age (years) 51.05 ± 15.67 44.29 ± 18.1 0.001
BMI (kg/m2) 26.85 ± 5.25 26.09 ± 3.75 NS
NC (cm) 36.31 ± 7.84 38.19 ± 5.94 NS
WC (cm) 84.51 ± 8.56 87.96 ± 12.56 NS
HC (cm) 99.1 ± 8.66 94.66 ± 12.68 <0.001
WHR 0.89 ± 0.08 0.97 ± 0.06 <0.001
FPG (mmol/L) 6.16 ± 1.39 6.86 ± 1.31 NS
HbA1c (%) 5.92 ± 0.67 6.13 ± 0.98 NS
TC (mmol/L) 5.51 ± 1.19 5.29 ± 1.09 NS
TG (mmol/L) 1.79 ± 0.98 2.01 ± 1.19 <0.001
HDL-C (mmol/L) 1.53 ± 0.35 1.33 ± 0.26 NS
LDL-C (mmol/L) 3.51 ± 1.08 3.48 ± 0.88 NS
SBP (mm Hg) 135.71 ± 15.14 133.41 ± 16.84 NS
DBP (mm Hg) 77.66 ± 8.47 78.96 ± 8.65 NS
Smoking (n, %) 2690 (40.17 %) 3547 (60.96 %) NS
Alcohol drinking (n, %) 893 (13.34 %) 985 (16.93 %) NS
Values represent mean ± SD, n (%). A p value ≤ 0.05 was considered statistically
significant. NS not significant (p > 0.05); BMI body mass index; NC neck
circumference; WC waist circumference; HC hip circumference; WHR waist-hip
ratio; FPG fasting plasma glucose; HbA1c hemoglobin A1c; TC total cholesterol;
TG triglyceride; HDL-C high-density lipoprotein cholesterol; LDL-C low-density
lipoprotein cholesterol; SBP systolic blood pressure; DBP diastolic blood pressure
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baseline, all-cause mortality at 8.8-year follow-up was
16.09 % (n = 2014), including 17.55 % (n = 1175) in women
and 14.42 % (n = 839) in men. There were 935 deaths
caused by CVD (mortality 7.47 %), in 505 women (mortal-
ity 7.54 %) and 430 men (7.39 %). In the high-NC group,
BMI showed a more significant influence on CVD events
and mortality. Likewise, in the high BMI group, NC also
significantly influenced the CVD outcomes.
Differences in CVD risk levels among NC groups be-
tween baseline and follow-up are listed in Table 2. At base-
line, significant differences among the NC groups were
found for BMI (p = 0.05), NC (p < 0.001), WC (p = 0.001),
HC (p < 0.001), WHR (p < 0.001), FPG (p = 0.004), TG
(p < 0.001), HDL-C (p < 0.001), and DBP (p = 0.039).
In all groups, BMI increased significantly between baseline
and follow-up (p < 0.001), as well as WC (p < 0.001), WHR
(p < 0.001), FPG (p = 0.032), TG (p = 0.027), TC (p = 0.019),
HDL-C (p = 0.019), LDL-C (p = 0.034), and SBP (p = 0.048).
However, age, TC, LDL-C, and SBP did not show signifi-
cant differences among NC groups at baseline (p = 0.632,
0.082, 0.116, and 0.137, respectively). NC, HC, and DBP did
not change significantly between baseline and follow-
up (p = 0.051, 0.127, and 0.166, respectively).
Compared with baseline, the number of CVD risk
factors in participants had increased from 2.6, 3.0,
and 3.4 to 3.5, 4.1, and 4.7 in the low-, medium-, and
high-NC cohorts (34, 36 and 38 %). The event-free
survival rate was 95.32, 80.15, and 75.47 %. CVD risk
factors and event free survival by NC group in years
are shown in Fig. 3. Every 2 years, we calculated the
number of CVD risk factors. The CVD risk factors
increased in number with NC in the mean 8.8 years
of follow-up, with subjects in the high-NC group hav-
ing 1.2 times as many risk factors as those of partici-
pants the low-NC group at the end of follow-up (at
baseline, 1.4 times). CVD-event-free survival also de-
creased in the 8.8 years of follow-up, with subjects in
the low-risk group having a 20 % higher CVD-event-
free survival rate than that of those in the high NC
group (p < 0.01).
Fig. 2 Incidence of CVD events and CVD mortality by NC and BMI. Data are presented as mean ± SEM. P-interaction represents the p value for
the interaction between the NC and BMI groups. All means are adjusted for age, smoking, and alcohol use. *p < 0.05; **p < 0.01; ***p < 0.001
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Discussion
To the best of our knowledge, this is the first prospect-
ive cohort study to evaluate the association between NC
and future CVD events and mortality and the first Chinese
population cohort to be assessed for an association between
fat distribution and CVD mortality. In the present pro-
spective study of a large cohort of Chinese people at high
risk of CVD, we examined the incidence of cardiovascular
events and mortality in people with different fat distribu-
tions (measured by NC and BMI). First, we observed that
NC is associated with cardiometabolic risk factors. Second,
a higher NC indicated a higher incidence of CVD events in
the future. Third, a higher NC was associated with higher
all-cause and CVD mortality.
Regional variations in adipocyte secretion have been ob-
served to make differential contributions to disease risk.
Subcutaneous fat and peripheral body fat stored predom-
inantly in the femoral, gluteal, and thigh regions help pro-
tect against ectopic fat accumulation. Consequently,
different accumulations of fat play different roles in
obesity-related diseases like insulin resistance, dyslipid-
emia, and fatty liver. Britton et al. found that visceral adi-
posity was associated with incident CVD and even cancer
[16]. In the Heinz Nixdorf Recall Study, epicardial fat was
proved be associated with fatal and nonfatal coronary
events, including CVD risk factors and incident myocar-
dial infarction in the general population [17]. More re-
cently, fat accumulation in not only the visceral region but
also other regions such as the liver, muscle, pericardial,
perivascular, and even perirenal areas was found to be as-
sociated with CVD and heart function [18–22].
Free fatty acid release from upper-body subcutaneous
fat was reported to be higher than that from lower-body
subcutaneous fat [23]. In recent years, several studies
have examined the association between NC and cardio-
metabolic risk factors. One of the most famous among
these studies was the Framingham Heart Study, which
demonstrated that NC is associated with CVD risk fac-
tors even after adjustment for visceral adipose tissue and
BMI, and considered NC to be a novel measure of car-
diometabolic risk [11]. The effectiveness of NC has been
demonstrated several times in the Chinese population.
In the Beijing Community Diabetes Study 4, NC was
positively associated with the metabolic syndrome in
Chinese people with T2DM [13]. In a study by Zhou,
NC was significantly correlated with all outcomes of
cardio-metabolic risk in both sexes [24]. In the Cardio-
metabolic Risk in Chinese study of a population of
apparently healthy Chinese adults, significant associa-
tions were found between high NC and increased risk of
insulin resistance and various CVD risk factors. These
researchers hold the viewpoint that NC could identify
those at high risk of CVD and T2DM [25]. Our results
were in line with these previous studies and other stud-
ies [9, 26]. In other words, the higher the NC, the
greater the risk that cardio-metabolic disturbances will
develop in the future. Our findings indicate that NC
may be a valid and powerful indicator of CVD.
Although a number of epidemiological studies have
demonstrated that diversity in body fat distribution
significantly predicts premature death, NC had been
used as a novel anthropometric measure of upper-trunk
Table 2 Differences in CVD risk levels among NC groups between baseline and follow-up
NC < 36 cm 36 cm≤ NC < 40 cm NC≥ 40 cm p values
Baseline Follow-up Baseline Follow-up Baseline Follow-up Time Group
n n = 2759 n = 2282 n = 6059 n = 5254 n = 3697 n = 2760 - -
Age (year) 46.33 ± 18.6 56.65 ± 19.12 48.64 ± 17.84 57.42 ± 18.81 47.96 ± 16.58 54.56 ± 16.28 - 0.632
BMI (kg/m2) 24.53 ± 5.47 28.4 ± 5.91 26.48 ± 4.75 30.4 ± 3.86 28.18 ± 6.92 30.34 ± 6.12 <0.001 0.05
NC (cm) 31.91 ± 4.2 32.5 ± 4.45 37.67 ± 1.58 37.23 ± 1.73 41.23 ± 1.21 41.55 ± 1.45 0.051 <0.001
WC (cm) 83.26 ± 10.33 84.34 ± 11.64 86.8 ± 9.72 87.54 ± 10.73 87.21 ± 10.96 89.54 ± 12.75 <0.001 0.001
HC (cm) 92.71 ± 10.43 92.53 ± 12.85 96.94 ± 9.22 97.22 ± 9.6 100.55 ± 10.53 103.65 ± 10.35 0.127 <0.001
WHR 0.88 ± 0.14 0.89 ± 0.16 0.92 ± 0.13 0.93 ± 0.15 0.97 ± 0.13 0.99 ± 0.16 <0.001 <0.001
FPG (mmol/L) 6.28 ± 1.33 6.25 ± 1.34 6.46 ± 1.26 6.59 ± 1.22 6.68 ± 1.29 6.77 ± 1.28 0.032 0.004
HbA1c (%) 5.78 ± 0.84 5.98 ± 1.05 5.98 ± 0.67 6.12 ± 0.73 6.25 ± 1.02 6.42 ± 1.35 0.048 0.137
TG (mmol/L) 1.72 ± 0.94 1.78 ± 1.08 1.9 ± 0.91 1.95 ± 0.96 2 ± 0.94 2.15 ± 1.11 0.027 <0.001
TC (mg/dL) 5.17 ± 1.17 5.32 ± 1.01 5.43 ± 1.15 5.67 ± 1.74 5.54 ± 1.67 5.73 ± 1.83 0.019 0.082
HDL-C (mg/dL) 1.67 ± 0.37 1.65 ± 0.27 1.43 ± 0.34 1.25 ± 0.36 1.27 ± 0.29 1.13 ± 0.36 0.006 <0.001
LDL-C (mg/dL) 3.17 ± 0.88 3.26 ± 0.93 3.57 ± 0.95 3.62 ± 1.02 3.61 ± 0.86 3.96 ± 1.01 0.034 0.116
SBP (mm Hg) 133.62 ± 16.78 136.9 ± 15.48 134.63 ± 14.95 137.21 ± 15.17 135.42 ± 14.96 140.07 ± 16.39 0.048 0.137
DBP (mm Hg) 76.27 ± 8.46 76.2 ± 7.7 77.55 ± 8.15 77.34 ± 7.98 80.92 ± 8.95 81.11 ± 9.35 0.166 0.039
Data represent mean ± SD. P interaction is age adjusted. Abbreviations as in Table 1
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body fat, but had not been assessed for its ability to pre-
dict mortality, especially surprising considering its
strong associations with CVD risk. The use of BMI com-
bined with measures of central obesity was analyzed
recently to assess mortality in subjects with coronary
disease [27]. The researchers focused on the role of cen-
tral obesity in people with normal weight and found that
normal weight with central obesity was associated with
the highest risk of mortality. However, although NC
measurements reduced the shortcomings of WC
measurements, which are easily affected by meals,
breathing, and clothing, NC was not considered in that
study.
This current study is the first prospective study of
NC to evaluate its predictive ability for CVD events
and mortality. Recent studies have proven the pre-
dictive ability of other indicators like WC, HC, and
WHR [28–32]; however, the results seemed incon-
sistent. In the Norfolk cohort, Canoy et al. con-
ducted a population-based prospective study to
Fig. 3 CVD risk factors and event free survival by NC groups. a Numbers of CVD risk factors in the different NC groups over time. b Event free survival by
NC group. Vertical axes show the number of CVD risk factors for each group (a) and percentage of event-free survival (b) during follow-up. Horizontal axes
reflect years of follow-up. The z-axis represents different NC cohorts (described in Methods). Traditional CVD risk factors are described in the Methods
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investigate body fat distribution and the risk of
CHD. They compared WC, WHR, and BMI and
found that abdominal obesity was more consistently
and strongly predictive of CHD than BMI, especially
with respect to the risk of obesity-related CHD [33].
WHR, WC, and even BMI were influenced by pos-
sible biological factors and confounders. Although
directly related to the development of CVD, these
indices still confuse clinicians when deciding how
they can best predict future events. In our study, NC
strongly affected CVD events and mortality, even in
the normal BMI group. Because it is not affected by
BMI, NC showed a more stable association with
CVD.
When the associations with BMI and NC were
assessed separately, a higher NC and BMI was associ-
ated with a higher incidence of CVD events, but for
any given NC, those with a larger BMI had a lower
mortality than those with a smaller BMI, regardless of
CVD mortality. In the general population, BMI in the
overweight and obese ranges has been associated with
higher overall mortality [34]. In our findings, BMI
remained predictive of CVD and CVD mortality. By
contrast, a high BMI was also found to contribute to
lower mortality in those with CVD and even in other
populations, as observed in many studies [35–37].
Furthermore, BMI has been demonstrated to have a
suboptimal correlation with body fat, especially in pa-
tients with CVD, because slightly overweight or obese
individuals can vary in body fat distribution and asso-
ciated metabolic risk factors [18, 38]. It suggested to
us that some individuals with a high BMI but a low
NC may be a typo among our participants, and even
those with a low BMI but a high NC. Our results
provided more evidence to support the obesity para-
dox and were consistent with previous conclusions.
NC could be a superior predictor of mortality in the
population at high-risk of CVD. Compared with BMI,
NC is not influenced by these paradoxes and showed
a stable ability to predict mortality.
To see the influence of sex on the results, we
analyzed the data for both sexes when comparing the
interactions of BMI and NC. Both BMI and NC had
different impacts on the incidence of CVD events,
and also CVD or all-cause mortality in men and
women, but to a different degree (Fig. 2). We found
increased risks associated with a higher NC value, but
with different trends in men and women. A possible
explanation for this phenomenon is that there is a
greater delivery of free fatty acid from visceral adipose
tissue to the liver in women than men [39] and free
fatty acid is considered to be one of the most import-
ant risk factors for CVD. However, all the interactions
were significant for both sexes (p < 0.05).
Strengths and limitations
The main strength of the present study is that we firstly
evaluated NC and its association with future CVD
outcomes in a high-risk population, with the cohort of
individuals manifesting both NC and BMI variability.
Furthermore, as this was designed as a prospective study,
we succeeded in attaining a high rate of follow-up and
minimized the possibility of bias resulting from loss of
follow-up. In addition, comparisons between men and
women within the same cohort have been scarce or not
reported adequately. When comparing the interactions of
BMI and NC, we calculated the data for both sexes.
Therefore, we could see the influence of sex on the results.
The large sample size of the study increased the precision
and provided us with extensive information that allowed
us to control for potential confounders.
Potential limitations of this study were the lack of com-
parisons for all anthropometric measures such as WC,
HC, and WHR. To consider all these variables together,
large-scale population-based studies are needed. A second
limitation is the absence of consideration of all the inter-
actions between risk factors like blood pressure or lipids.
Although they form part of the causal pathway, taking
these factors into account could help toward understand-
ing their role as mediating factors. Further studies are
needed to identify the relationship between NC and fatal
and nonfatal CVD events in the general population.
Conclusions
NC is associated with the future incidence of CVD events,
mortality, and all-cause mortality, particular among men
and women who have risk factors. A graded relationship
between NC and CVD events persisted in a population at
high risk of CVD. A higher NC indicated a higher inci-
dence of CVD events, mortality, and all-cause mortality in
the future. NC could be a superior, simpler, and more con-
sistent indicator of CVD and related mortality in the high-
CVD-risk population.
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